Pure Sunfarms signs cannabis supply agreement with Alberta
Village Farms International’s (NASDAQ:VFF) majority-owned joint venture Pure Sunfarms has entered into a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to supply recreational adult-use cannabis products to Alberta’s licensed private retailers.
The AGLC is the wholesaler to private retailers and the only authorized online retailer in Alberta. Pure Sunfarms expects to begin shipping its branded packaged dried flower, inclusive of pre-rolls in the coming weeks and months.
VFF shares are up 3% premarket.
FDA accepts Incyte’s NDA for pemigatinib
Under Priority Review status, FDA has accepted Incyte’s (NASDAQ:INCY) NDA for pemigatinib, a selective fibroblast growth factor receptor (FGFR) inhibitor, as a treatment for patients with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
The PDUFA target action date is May 30, 2020.
Aurora Cannabis opens flagship retail store
Aurora Cannabis (NYSE:ACB) announces the grand opening of its flagship retail store in North America’s largest mall located in Edmonton.
Aurora says the 11K-square foot store combines both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events.
ACB +4.18% premarket to $2.49.
QIAGEN and DiaSorin launch QuantiFERON-TB Plus test
QIAGEN (NYSE:QGEN) and DiaSorin (OTCPK:DSRLF) announced the U.S. launch of an automated workflow for QuantiFERON-TB Plus (QFT-Plus), the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s LIAISON platforms.
The FDA approved the LIAISON QuantiFERON-TB Plus Test, to offer streamlined laboratory automation for latent TB screening, supporting the conversion from tuberculin skin tests to modern blood-based QuantiFERON technology.
FDA clears Synchroseal and E-100 generator for da Vinci X/Xi platforms
The FDA has cleared Intuitive’s (NASDAQ:ISRG) two innovative technologies for two of the company’s da Vinci surgical systems to help improve procedures that require sealing.
Intuitive’s E-100 generator is its first internally developed robotic generator to power two key instruments on the da Vinci X and Xi systems.
Vessel Sealer Extend is the flagship instrument in the da Vinci energy sealing portfolio, and the new SynchroSeal instrument offers enhanced capabilities in general surgery.
